T-cell receptor usage in alloreactivity against HLA-B*2703 reveals significant conservation of the antigenic structure of B*2705

Tissue Antigens

Volumn 47, Issue 6, 1996, Pages 478-484

  Barber, D F ^a   Obeso, D ^a   Garcia Hoyo R ^a   Villadangos, J A ^a   Lopez De Castro J A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Alloreactivity; HLA B27 B*2703; T cell receptor

Indexed keywords

EPITOPE; HLA B ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CELL CLONE; CONTROLLED STUDY; CYTOTOXICITY; HLA SYSTEM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EPITOPES, T-LYMPHOCYTE; HLA-B ANTIGENS; HUMANS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 0029949256     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02589.x     Document Type: Article

References (34)

1. Sette A, Vitiello A, Reherman B et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994: 153: 5586-5592.
2. Rotzschke O, Falk K, Faath S, Rammensee HG. On the nature of peptides involved in T cell alloreactivity. J Exp Med 1991: 174: 1059-1071.
3. Elliott TJ, Eisen HN. Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc Natl Acad Sci USA 1990: 87: 5213-5217.
4. Villadangos JA, Galocha B, Lopez de Castro JA. Unusual topology of an HLA-B27 allospeciric T cell epitope lacking peptide specificity. J Immunol 1994: 152: 2317-2323.
5. Beall SS, Lawrence JV, Bradley DA et al. Beta-chain gene rearrangement and V beta gene usage in DPw2-specific T cells. J Immunol 1987: 139: 1320-1325.
6. Geiger MJ, Gorski J, Eckels DD. T cell receptor gene segment utilization by HLA-DR1-alloreactive T cell clones. J Immunol 1991. 147: 2082-2087.
7. Hurley CK, Steiner N, Wagner A, Geiger MJ, Eckels DD, Rosen-Bronson S. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation. J Immunol 1993: 150: 1314-1324.
8. bm12-reactive T cells. J Exp Med 1989: 169: 115-133.
9. Goronzy JJ, Xie C, Hu W, Lundy SK, Weyand CM. Restrictions in the repertoire of allospecific T cells. Contribution of the α-helical sequence polymorphism of HLA-DR molecules. J Immunol 1993: 151: 825-836.
10. Shirwan H, Chi D, Makowka L, Cramer DV. Lymphocytes infiltrating rat cardiac allograft express a limited repertoire of T cell receptor Vβ genes. J Immunol 1993: 151: 5228-5238.
11. Hall BL, Hand SL, Alter MD, Kirk AD, Finn OJ. Variables affecting the T cell receptor V beta repertoire heterogeneity of T cells infiltrating human renal allografts. Transpl Immunol 1993: 1: 217-227.
12. Steinle A, Reinhardt C, Jantzer P, Schendel DJ. In vivo expansion of HLA-B35 alloreactive T cells sharing homologous T cell receptors: evidence for maintenance of oligoclonally dominated allospecificity by persistent stimulation with an autologous MHC/peptide complex. J Exp Med 1995: 181: 503-513.
13. Barber DF, Lopez D, Lopez de Castro JA. T-cell receptor diversity in alloreactive responses against HLA-B27 (B*2705) is limited by multiple-level restrictions in both a and β chains. Eur J Immunol 1995: 25: 2479-2485.
14. Rojo S, Aparicio P, Hansen JA, Choo SY, Lopez de Castro JA. Structural analysis of an HLA-B27 functional variant, B27d, detected in American blacks. J Immunol 1987: 139: 3396-3401.
15. Choo SY, St. John T, Orr HT, Hansen JA. Molecular analysis of the variant alloantigen HLA-B27d (HLA-B*2703) identifies a unique single amino acid substitution. Hum Immunol 1988: 21: 209-219.
16. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6Å resolution. J Mol Biol 1991: 219: 277-319.
17. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992: 70: 1035-1048.
18. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995: 13: 587-622.
19. Lopez D, Garcia-Hoyo R, Lopez de Castro JA. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy. J Immunol 1994: 152: 5557-5571.
20. Villadangos JA, Galochu B, Garcia-Hoyo R, Lopez D, Garcia F, Lopez de Castro JA. Structure of HLA-B27 T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705. Eur J Immunol 1994: 24: 2548-2555.
21. Villadangos JA, Galocha B, Garcia F, Albar JP, Lopez de Castro JA. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703. Eur J Immunol 1995: 25: 2370-2377.
22. Bragado R, Lauzurica P, Lopez D, Lopez de Castro JA. T cell receptor V gene usage in a human alloreactive response: Shared structural features among HLA-B27-specific T cell clones. J Exp Med 1990: 171: 1189-1204.
23. Lauzurica P, Bragado R, Lopez D, Galocha B, Lopez de Castro JA. Asymmetric selection of T cell antigen receptor α- and β-chains in HLA-B27 alloreactivity. J Immunol 1992: 148: 3624-3630.
24. Aparicio P, Jaraquemada D, Lopez de Castro JA. Alloreactive cytolylic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens: selective involvement of CD8 in their class I-directed cytotoxicity. J Exp Med 1987: 165: 428-443.
25. Tuniguki N, Fruci D, Vigneti E et al. The peptide binding specificity of HLA-B27 subtypes. Immunogenetics 1994: 40: 192-198.
26. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Greenwood BM, McMichael AJ. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet 1991: 337: 640-643.
27. Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995: 7: 263-269.
28. Feltkamp TEW, Khan MA, Lopez de Castro JA. The pathogenetic role of HLA-B27. Immunol Today 1996: 17: 5-7.
29. Duchmann R, May E, Ackermann B, Goergen B, Meyer zum Büschenfelde K-H, Märker-Hermann E. HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self antigens are dominated by closely related TCRBV gene segment. A study in patients with reactive arthritis. Scand J Immunol 1996: 43: 101-108.
30. Roman-Roman S, Ferradini L, Azocar J, Genevee C, Hercend T, Triebel F. Studies on the human T cell receptor α/β variable region genes. I. Identification of 7 additional Vα subfamilies and 14 Jα gene segments. Eur J Immunol 1991: 21: 927-933.
31. Ferradini L, Roman S, Azocar J, Michalaki H, Triebel F, Hercend T. Studies on the human T cell receptor α/β variable region genes. II. Identification of four additional Vβ subfamilies. Eur J Immunol 1991: 21: 935-942.
32. Lopez D, Barber DF, Villadangos JA, Lopez de Castro JA. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2. J Immunol 1993: 150: 2675-2686.
33. Moss PA, Rosenberg WM, Zintzaras E, Bell JI. Characterization of the human T cell receptor α-chain repertoire and demonstration of a genetic influence on Vα usage. Eur J Immunol 1993: 23: 1153-1159.
34. Chothia C, Boswell DR, Lesk AM. The outline structure of the T-cell αβ receptor. EMBO J 1988: 7: 3745-3755.